#$%^&*AU2008207357C120170504.pdf#####PV PERUEH Res CIms 2008 Au8 3063I 42 di, spei pagsdc-15/O82008 Abstract New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise in particular administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkins lymphomas.